Radiomics and Radiogenomics in Neuro-Oncology: An Artificial Intelligence Paradigm – Volume 2: Genetics and Clinical Applications

Author: Saxena Ph.D., Sanjay

Edition: 1

ISBN: 9780443185090

Release Date: 01-11-2024

Package Dimensions: 9.3 x 6.3 x 0.8 inches

Languages: English

Binding: paperback

Number Of Pages: 358

Details: Radiomics and Radiogenomics in Neuro-Oncology: An Artificial Intelligence Paradigm―Volume 2: Genetics and Clinical Applications provides readers with a broad and detailed framework for radiomics and radiogenomics (R-n-R) approaches with AI in neuro-oncology. It delves into the study of cancer biology and genomics, presenting methods and techniques for analyzing these elements. The book also highlights current solutions that R-n-R can offer for personalized patient treatments, as well as discusses the limitations and future prospects of AI technologies.
Volume 1: Radiogenomics Flow Using Artificial Intelligence covers the genomics and molecular study of brain cancer, medical imaging modalities and their analysis in neuro-oncology, and the development of prognostic and predictive models using radiomics.
Volume 2: Genetics and Clinical Applications extends the discussion to imaging signatures that correlate with molecular characteristics of brain cancer, clinical applications of R-n-R in neuro-oncology, and the use of Machine Learning and Deep Learning approaches for R-n-R in neuro-oncology. Includes coverage of foundational concepts of the emerging fields of Radiomics and Radiogenomics Covers imaging signatures for brain cancer molecular characteristics, including Isocitrate Dehydrogenase Mutations (IDH), TP53 Mutations, ATRX loss, MGMT gene, Epidermal Growth Factor Receptor (EGFR), and other mutations Presents clinical applications of R-n-R in neuro-oncology such as risk stratification, survival prediction, heterogeneity analysis, as well as early and accurate prognosis Provides in-depth technical coverage of radiogenomics studies for difference brain cancer types, including glioblastoma, astrocytoma, CNS lymphoma, meningioma, acoustic neuroma, and hemangioblastoma